None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Body Mass Index between 18.5 and 24.9 (both inclusive), calculated as weight in kg/height in m2 Have no abnormal findings during screening within 21 days prior to administration of first dose of study drug, medical history and examination, laboratory evaluations Able to give written consent for participation.
Exclusion criteria
Exclusion criteria: 1. History of major illness related to haemopoietic, renal, hepatic, endocrine, pulmonary, central nervous, cardiovascular, immunological, dermatological, gastrointestinal or any other body system. 2. Smokers, who smoke 9 or more cigarettes/day and inability to abstain during the study. 3. Habituated to drinking tea, coffee (more than 5 cups/day) and inability to abstain during the study. 4. Habituated to tobacco/tobacco containing products/gutkha (more than 10gm/day) and inability to abstain during the study. 5. A positive result for hepatitis B, HIV antibody, Hepatitis C and syphilis [VDRL] tests. 6. History of difficulty with donating blood. 7. The receipt of an investigational product or participation in a drug research study within a period of 90 days prior to the first of study drug. 8. History of Hypersensitivity to Amoxicillin
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NATimepoint: NA | — |
Secondary
| Measure | Time frame |
|---|---|
| NATimepoint: NA | — |
Countries
India
Contacts
Maharashtra Medical Council